Copper-boosting compounds: a novel concept for antimycobacterial drug discovery. - Wikidata - awgldk - TriplyDB

Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.

Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.

http://www.wikidata.org/entity/Q36558441

about

Copper homeostasis in Mycobacterium tuberculosis Copper complexation screen reveals compounds with potent antibiotic properties against methicillin-resistant Staphylococcus aureus.Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis.Pharmacological activity of metal binding agents that alter copper bioavailability.Mycobacterium tuberculosis and Copper: A Newly Appreciated Defense against an Old Foe?Mycobacteria, metals, and the macrophage Combinatorial phenotypic screen uncovers unrecognized family of extended thiourea inhibitors with copper-dependent anti-staphylococcal activity.Copper(II)-Bis(Thiosemicarbazonato) Complexes as Antibacterial Agents: Insights into Their Mode of Action and Potential as Therapeutics.Development of a web-based tool for automated processing and cataloging of a unique combinatorial drug screen.A multicopper oxidase is required for copper resistance in Mycobacterium tuberculosis Porins increase copper susceptibility of Mycobacterium tuberculosis.8-Hydroxyquinolines Are Boosting Agents of Copper-Related Toxicity in Mycobacterium tuberculosis.Genetic-and-Epigenetic Interspecies Networks for Cross-Talk Mechanisms in Human Macrophages and Dendritic Cells during MTB Infection.Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against Mycobacterium tuberculosis Copper tolerance and virulence in bacteria.Survival in amoeba--a major selection pressure on the presence of bacterial copper and zinc resistance determinants? Identification of a "copper pathogenicity island".Copper(II)-bis(thiosemicarbazonato) complexes as anti-chlamydial agents.Bacterial killing in macrophages and amoeba: do they all use a brass dagger?Disulfiram and Copper Ions Kill Mycobacterium tuberculosis in a Synergistic Manner.A Macrophage Infection Model to Predict Drug Efficacy Against Mycobacterium Tuberculosis.Inhibition of respiratory complex I by copper(ii)-bis(thiosemicarbazonato) complexes.Antimicrobial effects of copper(II) bis(thiosemicarbazonato) complexes provide new insight into their biochemical mode of action.Copper Ions and Coordination Complexes as Novel Carbapenem Adjuvants.Silver potentiates aminoglycoside toxicity by enhancing their uptake.

P2860

Q26829405-C3031109-8793-4DA9-98C0-8819543B1359 Q33798397-61123666-B1FE-4E70-9AD3-AB20CEEA72A3 Q35180731-51C14D45-2785-4BFA-A090-D5F803423F20 Q35587484-D132D1D5-6397-4D89-BAA7-44F40775644F Q35905306-5C528DF1-E2B7-4EE2-9F4B-CE23EC8411F0 Q35907046-BB1B5C96-8D89-4DE8-8D5B-0EDD0014C3AA Q35943409-F02FC7DC-A251-4D02-B594-15F4BA989E50 Q36075898-7ADE5DCA-0430-45A1-8B98-927EB07118CF Q37038087-6F783914-A3CB-441F-83E2-00D06586AD53 Q37124871-C251F882-3FC1-4DBD-B731-F6C010B5D18D Q37264105-041A6893-1B82-44A0-8D2B-9976141C9005 Q37287687-331BEA56-8805-45C5-9C55-99DD6C460B1C Q37345281-BC7E9695-F0FE-4665-BA45-3E3EFFE55F87 Q37722890-67546156-C3EC-427E-9D65-2BC3B7743969 Q38344436-19CB58B3-01AE-4DDA-BDC0-5BDC1C18B382 Q38531447-689E81A7-16A1-4DE1-B28E-8AEA64CAF847 Q38638732-1C4D6D63-3513-4C88-A982-CF647B0A5B95 Q39345930-421D279F-7F51-41D6-AF9B-58CAA146CEE7 Q40879670-9B04AC75-D04A-44B5-A46C-87F35F381E37 Q41529160-07A2BAA3-753E-4C51-8BD0-9277DFFE2178 Q41679298-B8A90903-75EB-46E3-99B1-C535624C73CF Q42232549-3FEC1508-24A2-457A-AADF-EFF56D1FE201 Q47709666-10206183-FF52-4181-A0DA-E5E2BEAC316B Q48313015-3E537722-55B5-4DD6-9E2A-2079C8559680

P2860

Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.

http://www.wikidata.org/entity/Q36558441

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.

@ast

Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.

@en

type

label

Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.

@ast

Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.

@en

prefLabel

Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.

@ast

Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.

@en

P1433

Q36558441-2006DA3D-C69D-4E6A-8AC7-85A09A7C638B

P1476

Q36558441-38922B91-6B77-45AE-B134-FF8D79632599

P2093

Q36558441-0819C60C-27DA-4A12-B91B-3D6B32C0FF59

Q36558441-1F35989C-2B94-46DD-86C3-52C6B8F9BEF4

Q36558441-4B213811-5E4D-42BB-BA1D-C216A01CF134

Q36558441-65C81AF6-F76F-4C45-B954-E066FF88C82E

Q36558441-7A3590BD-60D1-4424-B5F3-43C8748F1C2F

Q36558441-D20C5733-AA67-4C56-88C4-2E91432A464F

P2860

Q36558441-0D7BCCAB-64A9-4810-93CC-DD97D038D670

Q36558441-11F6F123-7218-4A42-B43B-0F1DB71E7D7A

Q36558441-21E3F136-753D-4551-9AFB-4716F1D91341

Q36558441-4609A6D8-918B-4608-BB49-D06EC81DC133

Q36558441-46A1A232-54B5-4B19-885D-434DB3E05B74

Q36558441-4F17B445-75C8-45C0-899F-E3C68C33ED84

Q36558441-6D82B18C-23C3-45E9-A6F1-BEA44C179CEC

Q36558441-7342891B-F271-4947-88E1-B385B015F756

Q36558441-76FA0E34-B9BF-423A-9AED-64C22CD6A92A

Q36558441-7C0385DA-CF18-450F-96C1-4BB9504A62BE

P304

Q36558441-DFCC9EE3-E34F-4B14-A8CD-799FF75607A9

P31

Q36558441-80AD648B-1FE2-4D53-975C-500CED335E47

P356

Q36558441-9D88853D-C31E-4479-9BF5-A11CC1F363A9

P407

Q36558441-B68EE663-FB53-4542-9DA1-98E02255E2A6

P433

Q36558441-9F4016A1-4498-45E2-B2DC-B460DD611056

P478

Q36558441-2CDED4B4-C1B2-4687-BFF3-D4B87759ACDD

P50

Q36558441-179D7ABE-54B8-421B-9187-F3911BDE577F

Q36558441-1DB2E9F7-4A61-46F0-A5C6-82F9AD2D7370

Q36558441-87855EE5-A61A-461A-BCAB-C63A550F25D1

P577

Q36558441-4ECC476D-4F1B-4F1B-863A-31F3807E2596

P698

Q36558441-14795FF2-5F1F-444B-8BA0-4BC9271DF9B4

P932

Q36558441-20B9AE97-49BF-482E-B6D5-EB422A540C30

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.

@en

P2093

Alexander Speer

http://www.w3.org/2001/XMLSchema#string

Gregory J Harber

http://www.w3.org/2001/XMLSchema#string

Randall J Basaraba

http://www.w3.org/2001/XMLSchema#string

Stefan H Bossmann

http://www.w3.org/2001/XMLSchema#string

Suzanne M Michalek

http://www.w3.org/2001/XMLSchema#string

Tej B Shrestha

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis

CtpV: a putative copper exporter required for full virulence of Mycobacterium tuberculosis

Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling

Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.

Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.

High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.

A role for the ATP7A copper-transporting ATPase in macrophage bactericidal activity.

Disulfiram reactivates latent HIV-1 expression through depletion of the phosphatase and tensin homolog.

Copper resistance is essential for virulence of Mycobacterium tuberculosis

Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice

P304

1089-1091

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.01781-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Michael Niederweis

Frank Wolschendorf

P577

2012-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23254420

http://www.w3.org/2001/XMLSchema#string

P932

3553712

http://www.w3.org/2001/XMLSchema#string